Literature DB >> 24366227

IBD: Patients with IBD find symptom relief in the Cannabis field.

Rudolf Schicho1, Martin Storr2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24366227      PMCID： PMC3947743          DOI： 10.1038/nrgastro.2013.245

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

1.  A prospective study of cigarette smoking and the risk of inflammatory bowel disease in women.

Authors:  Leslie M Higuchi; Hamed Khalili; Andrew T Chan; James M Richter; Athos Bousvaros; Charles S Fuchs
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

2.  Cannabis use amongst patients with inflammatory bowel disease.

Authors:  Simon Lal; Neeraj Prasad; Manijeh Ryan; Sabrena Tangri; Mark S Silverberg; Allan Gordon; Hillary Steinhart
Journal:  Eur J Gastroenterol Hepatol       Date:  2011-10       Impact factor: 2.566

Review 3.  Pharmacological actions of cannabinoids.

Authors:  R G Pertwee
Journal:  Handb Exp Pharmacol       Date:  2005

4.  The endogenous cannabinoid system in the gut of patients with inflammatory bowel disease.

Authors:  A Di Sabatino; N Battista; P Biancheri; C Rapino; L Rovedatti; G Astarita; A Vanoli; E Dainese; M Guerci; D Piomelli; S L F Pender; T T MacDonald; M Maccarrone; G R Corazza
Journal:  Mucosal Immunol       Date:  2011-04-06       Impact factor: 7.313

5.  Impact of cannabis treatment on the quality of life, weight and clinical disease activity in inflammatory bowel disease patients: a pilot prospective study.

Authors:  Adi Lahat; Alon Lang; Shomron Ben-Horin
Journal:  Digestion       Date:  2011-11-17       Impact factor: 3.216

Review 6.  The endocannabinoid system in inflammatory bowel diseases: from pathophysiology to therapeutic opportunity.

Authors:  Mireille Alhouayek; Giulio G Muccioli
Journal:  Trends Mol Med       Date:  2012-08-21       Impact factor: 11.951

7.  Cannabis induces a clinical response in patients with Crohn's disease: a prospective placebo-controlled study.

Authors:  Timna Naftali; Lihi Bar-Lev Schleider; Iris Dotan; Ephraim Philip Lansky; Fabiana Sklerovsky Benjaminov; Fred Meir Konikoff
Journal:  Clin Gastroenterol Hepatol       Date:  2013-05-04       Impact factor: 11.382

8.  Marijuana use patterns among patients with inflammatory bowel disease.

Authors:  Jessica Ravikoff Allegretti; Andrew Courtwright; Matthew Lucci; Joshua R Korzenik; Jonathan Levine
Journal:  Inflamm Bowel Dis       Date:  2013-12       Impact factor: 5.325

9.  Ulcerative colitis induces changes on the expression of the endocannabinoid system in the human colonic tissue.

Authors:  Lucia Marquéz; Juan Suárez; Mar Iglesias; Francisco Javier Bermudez-Silva; Fernando Rodríguez de Fonseca; Montserrat Andreu
Journal:  PLoS One       Date:  2009-09-04       Impact factor: 3.240

Review 10.  A potential role for GPR55 in gastrointestinal functions.

Authors:  Rudolf Schicho; Martin Storr
Journal:  Curr Opin Pharmacol       Date:  2012-10-10       Impact factor: 5.547
  10 in total
  7 in total

1.  Therapeutic Use of Cannabis in Inflammatory Bowel Disease.

Authors:  Waseem Ahmed; Seymour Katz
Journal:  Gastroenterol Hepatol (N Y)       Date:  2016-11

2.  Cannabis and Pediatric Inflammatory Bowel Disease: Change Blossoms a Mile High.

Authors:  Edward J Hoffenberg; Heike Newman; Colm Collins; Sally Tarbell; Kristina Leinwand
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-02       Impact factor: 2.839

3.  Symptoms and Extraintestinal Manifestations in Active Cannabis Users with Inflammatory Bowel Disease.

Authors:  Matthew D Coates; Shannon Dalessio; Vonn Walter; August Stuart; Nana Bernasko; Andrew Tinsley; Sanam Razeghi; Emmanuelle D Williams; Kofi Clarke; Kent Vrana
Journal:  Cannabis Cannabinoid Res       Date:  2021-03-24

Review 4.  Potential for endocannabinoid system modulation in ocular pain and inflammation: filling the gaps in current pharmacological options.

Authors:  J Daniel Lafreniere; Melanie E M Kelly
Journal:  Neuronal Signal       Date:  2018-11-02

5.  QingBai decoction regulates intestinal permeability of dextran sulphate sodium-induced colitis through the modulation of notch and NF-κB signalling.

Authors:  Jun-Chao Lin; Jie-Qiong Wu; Fang Wang; Feng-Ying Tang; Jia Sun; Bing Xu; Mingzuo Jiang; Yi Chu; Di Chen; Xiaowei Li; Song Su; Yujie Zhang; Nan Wu; Shaoqi Yang; Kaichun Wu; Jie Liang
Journal:  Cell Prolif       Date:  2019-01-18       Impact factor: 6.831

6.  Endocannabinoid System as a Promising Therapeutic Target in Inflammatory Bowel Disease - A Systematic Review.

Authors:  Szymon Hryhorowicz; Marta Kaczmarek-Ryś; Aleksandra Zielińska; Rodney J Scott; Ryszard Słomski; Andrzej Pławski
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

Review 7.  Parameters of the Endocannabinoid System as Novel Biomarkers in Sepsis and Septic Shock.

Authors:  J Daniel Lafreniere; Christian Lehmann
Journal:  Metabolites       Date:  2017-11-01
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.